
VTR Biotech Group Establishes European Presence with Launch of Vnzymes Subsidiary and Frankfurt Headquarters
New Subsidiary Expands European Access to Sustainable Bio-Solutions for Animal Nutrition, Industrial Enzymes, and Sustainable Agriculture
FRANKFURT, Germany — November 15, 2025 — Vnzymes, the newly established European subsidiary and brand of VTR Biotech Group, today officially announced the grand opening of its regional headquarters in Frankfurt. The opening marks a major milestone in VTR Biotech’s international growth strategy and underscores its commitment to advancing sustainable agriculture and biotechnology across Europe.
Leveraging VTR Biotech’s global scientific capabilities and 30-year industry foundation, Vnzymes delivers targeted bio-solutions that improve operational efficiency, nutrient digestibility, and sustainable farming practices. The Frankfurt office will serve as the commercial and operational hub for European markets, coordinating research and development, technical services, and localized commercial strategies.
“For more than 30 years, VTR Biotech has remained dedicated to its core mission: ‘Bioscience Impact Tomorrow’—advancing the research and application of enzyme preparations, biosynthetic products, and plant extracts,” said Cindy Chen, CEO of Vnzymes. “With the launch of Vnzymes in Europe, we are building a dedicated regional platform that combines our global technical expertise with local market requirements to deliver measurable value for our partners, clients, and communities.”
Specialized Portfolio for Animal Health and Nutrition
Vnzymes enters the European market with an established core portfolio engineered for modern livestock efficiency and sustainable production:
-
Advanced Enzyme Solutions: High-performance xylanase and phytase enzymes designed to enhance nutrient digestibility, optimize phosphorus utilization, support gut health, and improve livestock growth performance.
-
Natural Feed Additives: Phytogenic solutions derived from Macleaya cordata that stimulate feed intake, boost natural immunity, improve antioxidant capacity, and support antibiotic-free production standards.
“True globalization requires more than expanding geographic reach,” added Dr. Wang Yufeng, Senior Technical Director at Vnzymes. “It requires delivering meaningful, localized innovations backed by a strong global framework. Vnzymes is uniquely positioned to fulfill this role across the European market.”
Media contact
Contact Name: Cindy Chen
Company Name: Vnzymes
Website: www.vnzymes.com
Email: [email protected]
Disclaimer:
This content is provided by Vnzymes. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or business advice. All investments carry inherent risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Neither the media platform nor the publisher shall be held responsible for any inaccuracies, misrepresentations, or financial losses resulting from the use or reliance on the information in this press release. Speculate only with funds you can afford to lose. In the event of any legal claims or concerns regarding this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page.

